Piramal Pharma acquires controlling 40 per cent stake in Yapan Bio
August 19, 2026 | 11:51
Healthcare firm Piramal Pharma completed its purchase of an additional 40 per cent stake in CDMO Yapan Bio on 19 August 2026 to expand vaccine manufacturing.
Piramal Pharma expands peptide API facility with spray drying
August 05, 2026 | 15:20
Piramal Pharma Solutions launched a state-of-the-art spray drying suite at its dedicated peptide API facility, expanding manufacturing capacity for the global CDMO under Piramal Pharma.
Piramal Pharma announces Q1 FY27 results
July 30, 2026 | 12:01
Piramal Pharma, listed on both NSE and BSE, announced its standalone and consolidated results for the first quarter ended 30 June 2026, covering its global pharmaceutical and wellness business.
Mobile Version